HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuang Wu Selected Research

Androgen Receptors (Androgen Receptor)

8/2020Correction to: Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells.
11/2019Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.
6/2017Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism.
5/2017Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma.
5/2014Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuang Wu Research Topics

Disease

49Neoplasms (Cancer)
12/2022 - 12/2010
34Infections
03/2021 - 10/2010
20Hepatocellular Carcinoma (Hepatoma)
12/2022 - 10/2010
14Stroke (Strokes)
08/2022 - 11/2015
12Atrial Fibrillation
08/2022 - 03/2016
12Inflammation (Inflammations)
04/2022 - 01/2011
11Chronic Hepatitis C
02/2018 - 01/2011
10COVID-19
04/2022 - 01/2020
8Hemorrhage
08/2022 - 01/2020
8Liver Cirrhosis (Hepatic Cirrhosis)
09/2018 - 01/2013
7Myocardial Infarction
02/2022 - 03/2005
7Thrombosis (Thrombus)
02/2022 - 03/2015
7Heart Failure
01/2022 - 07/2007
7Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2018
7Neoplasm Metastasis (Metastasis)
01/2021 - 05/2012
7Liver Diseases (Liver Disease)
02/2018 - 01/2014
7Body Weight (Weight, Body)
01/2017 - 07/2007
7Chronic Hepatitis B
12/2015 - 01/2011
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 02/2004
6Breast Neoplasms (Breast Cancer)
01/2022 - 07/2014
6Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2014
5Glioblastoma (Glioblastoma Multiforme)
11/2022 - 01/2020
5Acute Coronary Syndrome
08/2022 - 11/2020
5Brain Ischemia (Cerebral Ischemia)
08/2022 - 11/2015
5Ischemic Stroke
06/2022 - 01/2016
5Disease Progression
01/2022 - 10/2010
5Glioma (Gliomas)
05/2021 - 03/2019
5Occupational Stress
01/2020 - 01/2018
4Ulcerative Colitis
04/2022 - 07/2016
4Hypertension (High Blood Pressure)
01/2022 - 01/2016
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 06/2019
4Diabetes Mellitus
01/2022 - 05/2015
4Obesity
01/2022 - 01/2014
4Epilepsy (Aura)
01/2022 - 01/2017
4Autoimmune Hepatitis
02/2018 - 09/2015
4Hepatitis
02/2018 - 01/2014
4Acute Liver Failure (Fulminant Hepatic Failure)
02/2017 - 05/2013
4Hepatitis B
05/2016 - 10/2010
3Reperfusion Injury
08/2022 - 11/2015
3Cerebral Infarction
08/2022 - 11/2015
3Lung Neoplasms (Lung Cancer)
06/2022 - 02/2004
3Hypoxia (Hypoxemia)
06/2022 - 02/2015
3Cognitive Dysfunction
01/2022 - 01/2017
3Triple Negative Breast Neoplasms
01/2022 - 01/2018
3Pneumonia (Pneumonitis)
03/2021 - 10/2018
3Temporal Lobe Epilepsy
01/2021 - 01/2018
3Colonic Neoplasms (Colon Cancer)
10/2020 - 11/2011
3Hepatitis C
01/2020 - 04/2013
3Virus Diseases (Viral Diseases)
01/2020 - 03/2011
3Anemia
05/2016 - 01/2012
2Brain Neoplasms (Brain Tumor)
11/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2007
17Biomarkers (Surrogate Marker)IBA
12/2022 - 06/2014
13Ribavirin (Virazole)FDA LinkGeneric
01/2019 - 01/2011
11Antiviral Agents (Antivirals)IBA
12/2022 - 04/2011
10InterferonsIBA
01/2021 - 01/2011
9Therapeutic UsesIBA
08/2022 - 01/2016
9VaccinesIBA
08/2021 - 01/2014
8Pharmaceutical PreparationsIBA
01/2022 - 07/2014
8MicroRNAs (MicroRNA)IBA
10/2019 - 11/2011
7Messenger RNA (mRNA)IBA
08/2022 - 05/2003
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 12/2016
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2014
7RNA (Ribonucleic Acid)IBA
05/2021 - 09/2015
5Biological ProductsIBA
10/2022 - 01/2018
5AnticoagulantsIBA
08/2022 - 03/2016
5CytokinesIBA
03/2022 - 10/2010
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 09/2011
5Androgen Receptors (Androgen Receptor)IBA
08/2020 - 05/2014
5Endoplasmic Reticulum Chaperone BiPIBA
06/2017 - 01/2014
5entecavirFDA Link
05/2016 - 09/2011
42'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
08/2022 - 01/2022
4Nucleic AcidsIBA
04/2022 - 01/2019
4SofosbuvirIBA
01/2018 - 01/2016
4Small Interfering RNA (siRNA)IBA
01/2018 - 01/2014
4Hepatitis B e AntigensIBA
12/2015 - 10/2010
4Alanine Transaminase (SGPT)IBA
05/2015 - 09/2011
4Lamivudine (Epivir)FDA Link
01/2013 - 04/2011
3Long Noncoding RNAIBA
05/2022 - 01/2020
3omega-Chloroacetophenone (Mace)IBA
02/2022 - 11/2020
3Transaminases (Aminotransferases)IBA
01/2022 - 02/2017
3LipidsIBA
01/2021 - 12/2009
3Blood Glucose (Blood Sugar)IBA
01/2021 - 05/2015
3CollagenIBA
01/2021 - 07/2007
3Peptides (Polypeptides)IBA
01/2020 - 01/2016
3PolymersIBA
11/2019 - 02/2016
3Carrier Proteins (Binding Protein)IBA
11/2019 - 12/2016
3Thromboplastin (Tissue Factor)IBA
03/2018 - 01/2016
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017 - 11/2014
3Caspase 3 (Caspase-3)IBA
11/2016 - 07/2007
3Isoproterenol (Isoprenaline)FDA LinkGeneric
12/2007 - 07/2007
2Free RadicalsIBA
11/2022 - 02/2021

Therapy/Procedure

42Therapeutics
12/2022 - 02/2004
8Drug Therapy (Chemotherapy)
06/2022 - 02/2004
5Percutaneous Coronary Intervention
08/2022 - 11/2020
5Heavy Ion Radiotherapy
01/2021 - 01/2018
4Aftercare (After-Treatment)
01/2022 - 01/2017
4Radiotherapy
01/2021 - 02/2004
3Stents
02/2022 - 11/2020
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 12/2017